Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28.9M
-
Number of holders
-
139
-
Total 13F shares, excl. options
-
20.2M
-
Shares change
-
-490K
-
Total reported value, excl. options
-
$444M
-
Value change
-
-$121M
-
Number of buys
-
91
-
Number of sells
-
-60
-
Price
-
$21.95
Significant Holders of CASTLE BIOSCIENCES INC - Common Stock (CSTL) as of Q2 2022
173 filings reported holding CSTL - CASTLE BIOSCIENCES INC - Common Stock as of Q2 2022.
CASTLE BIOSCIENCES INC - Common Stock (CSTL) has 139 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.2M shares
of 28.9M outstanding shares and own 70.06% of the company stock.
Largest 10 shareholders include WASATCH ADVISORS INC (3.71M shares), VANGUARD GROUP INC (1.21M shares), Bellevue Group AG (941K shares), RTW INVESTMENTS, LP (914K shares), Granahan Investment Management, LLC (907K shares), MILLENNIUM MANAGEMENT LLC (902K shares), KORNITZER CAPITAL MANAGEMENT INC /KS (642K shares), CITADEL ADVISORS LLC (631K shares), PALISADE CAPITAL MANAGEMENT LLC/NJ (579K shares), and GW&K Investment Management, LLC (516K shares).
This table shows the top 139 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.